Magnitude Biosciences Ltd

📍 Durham, United Kingdom🗓 Founded 2018👥 23 employees💰 Last funded Mar 2025
Biotechnology Research🌐 magnitudebiosciences.com
Website LinkedIn
An innovative C. elegans company, using our expertise and technology to provide quantified non-invasive assays of health outcomes for biotech, nutrition and other industries and research interests. - Prescreen compounds to reduce the number of experiments in mammals - Find effective and safe concentration ranges
 - Test mutants in signalling pathways - Screen libraries of mutants
 - Screen compound libraries 
 - Combine compounds and mutants
 - Adapt technology to address your questions We are a team of experts with a proven track record of: Designing customised C. elegans studies to provide answers to your specific ageing research questions Integrating C. elegans into drug discovery pipelines Working with innovative biotech and pharma companies Providing relevant, standardised, data rich assays
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Magnitude Biosciences Ltd?
Magnitude Biosciences Ltd has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Magnitude Biosciences Ltd last raise funding?
The most recent investment in Magnitude Biosciences Ltd recorded on gritt.io was in March 2025.
When was Magnitude Biosciences Ltd founded?
Magnitude Biosciences Ltd was founded in 2018.
What industry is Magnitude Biosciences Ltd in?
Magnitude Biosciences Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Magnitude Biosciences Ltd based?
Magnitude Biosciences Ltd is headquartered in Durham, United Kingdom.